This issue is complicated as ICM expression on TILs is highly varied between cancers and lymphocyte populations; for example, NSCLC and head and neck squamous cell carcinoma display an increased population of CD45+/CD3+ TILs while other cancer types have a reduction in this population [81]. Here, PTPRC is linked to cancer.